Relief for Sun Pharma as regulator’s probe unearths no evidence of fraud: report – FiercePharma

Sun Pharma might soon escape the whistleblower complaints weighing on its shares. A preliminary probe by India’s securities watchdog, focused primarily on two of the allegations, found no violation of securities laws at the drugmaker. Read More